Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG 77-06, a phase III study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 4, 1998, Pages 769-782

  Asbell, Sucha O ^a   Martz, Karen L ^b   Shin, Kyu H ^c   Sause, William T ^d   Doggett, R L ^e   Perez, Carlos A ^f   Pilepich, Miljenko V ^g  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b RTOG Headquarters   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d LDS HOSPITAL   (United States)

^e Sutter Community Hospitals   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Catherine McAuley Health Center   (United States)

Author keywords

Lymphangiogram; Prostate cancer; Radiation therapy; Staging lymphadenectomy; Surgical staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031898828     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00926-7     Document Type: Article

References (46)

1. Asbell S. O., Krall J. M., Pilepich M. V., Baerwald H., Sause W. T. Elective pelvic irradiation in Stage A2, B carcinoma of the prostate - analysis of RTOG 7706. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;1307-1316.
2. Asbell S. O., Martz K. L., Pilepich M. V., Baerwald H. H., Sause W. T., Doggett R. L., Perez C. A. Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG phase III study for A2 and B prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 17:1989;945-951.
3. Donohue R. E., Mani J. H., Whitesel J. A., Mohr S., Scanavino D., Augspurfger R. R., Biber R. J., Fauver H. E., Wettlaufer J. N., Pfister R. R. Pelvic lymph node dissection Guide to patient management in clinically locally confined adenocarcinoma of the prostate . Urology. 20:1982;559-565.
4. Jewett H. J. The present status of radical prostatectomy for stage A and B prostatic cancer. Urol. Clin. N. Am. 2:1975;105-124.
5. Murphy G. P., Gaeta J. F., Pickren J., Wajsman Z. Current status of classification and staging of prostatic cancer. Cancer. 45:1980;1889-1895.
6. Hanks G. E., Perez C. A., Kozar M. B., Asbell S. O., Pilepich M. V., Kaplan R. The PSA confirmation of cure at 10 years of T1B,T2,N0,M0 prostate cancer patients treated in RTOG protocol 77-06 with external beam irradiation. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;289-292.
7. Kaplan E. L., Meier P. Nonparametric estimation for incomplete observation. J. Am. Stat. Assoc. 53:1958;457-481.
8. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Natl. Cancer Inst. 22:1959;719-748.
9. Gray R. J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 16:1988;1141-1154.
10. Hanks G. E., Krall J. M., Pilepich M. V., Asbell S. O., Perez C. A., Rubin P., Sause W. T., Doggett S. Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer Implications of RTOG data for patient management and trial design and stratification . Int. J. Radiat. Oncol. Biol. Phys. 23:1992;293-298.
11. Hricak H., Dooms G. C., Jeffrey R. B., et al. Prostatic carcinoma Staging by clinical assessment, CT, and MRI imaging . Radiology. 162:1987;331-336.
12. Platt J. F., Bree R. L., Schwab R. E. The accuracy of CT in the staging of carcinoma of the prostate. AJR. 149:1987;315-318.
13. Engeler C. E., Wasserman N. F., Zhang G. Preoperative assessment of prostatic carcinoma by computerized tomography. Urology. 40:1992;346-350.
14. Rorvik J., Halvorsen O. J., Espeland A., Haukaas S. Inability of refined CT to assess local extent of prostatic cancer. Acta Radiol. 34:1993;39-42.
15. Perez C. A. Carcinoma of the prostate A model for management under impending health care system reform . Radiology. 196:1995;309-322.
16. Oyen R. H., Van Poppel H. P., Ameye F. E., Van de Voorde W. A., Baert A. L., Baert L. V. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy prospective study of 285 patients . Radiology. 190:1994;315-322.
17. Clements R., Griffiths G. J., Peeling W. B. Staging prostatic cancer (review). Clin. Radiol. 46:1992;225-231.
18. McSherry S. A., Levy F., Scheibler M. L., Keefe B., Dent G. A., Mohler J. L. Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer Comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging . J. Urol. 146:1991;85-89.
19. Rifkin M. D., Zerhouni E. A., Gatsonis C. A., et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. N. Engl. J. Med. 323:1990;621-626.
20. Hamper U. M., Sheth S., Walsh P. C., Holtz P. M., Epstein J. I. Capsular transgression of prostatic carcinoma Evaluation with transrectal US with pathologic correlation . Radiology. 178:1991;791-795.
21. Terris M. K., McNeal J. E., Stamey T. A. Invasion of the seminal vesicles by prostatic cancer Detection with transrectal sonography . AJR. 155:1990;811-815.
22. Schiebler M. L., Yankaskas B. C., Tempany C., et al. MRI imaging in adenocarcinoma of the prostate Interobserver variation and efficacy for determining stage C disease . AJR. 158:1992;559-562.
23. Chelsky M. J., Schnall M. D., Seidmon E. J., Pollack H. M. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J. Urol. 150:1993;391-395.
24. Quinn S. F., Franzini D. A., Demlow T. A., et al. MRI imaging of prostate cancer with an endorectal surface coil technique Correlation with whole-mount specimens . Radiology. 190:1994;323-327.
25. Schnall M. D., Imai Y., Tomaszewski J., Pollack H. M., Lenkinski R. E., Kressel H. Y. Prostate cancer Local staging with endorectal surface coil MRI imaging . Radiology. 178:1991;797-802.
26. Schiebler M. L., Schnall M. D., Pollack H. M., et al. Current role of MRI imaging in the staging of adenocarcinoma of the prostate. Radiology. 189:1993;339-352.
27. Zagars G. K., von Eschenbach A. C., Ayala A. G. Prognostic factors in prostate cancer Analysis of 874 patients treated with radiation therapy . Cancer. 72:1993;1709-1725.
28. Zietman A. L., Coen J. J., Dallow K. C., Shipley W. U. The treatment of prostate cancer by conventional radiation therapy An analysis of long-term outcome . Int. J. Radiat. Oncol. Biol. Phys. 32:1995;287-292.
29. D'Amico A. V., Whittington R., Malkowicz S. B., Schultz D. A method of determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;473-477.
30. Geist R. W. Reference range for prostate-specific antigen levels after external beam radiation therapy for adenocarcinoma of the prostate. Urology. 45:1995;1016-1021.
31. Liebner E. J., Stefano S. An evaluation of lymphography with nodal biopsy in localized carcinoma of the prostate. Cancer. 45:1980;728-734.
32. Prando A., Wallace S., von Eschemback A. C., Jing B., Rosengren J., Hussey D. H. Lymphangiography in staging of carcinoma of the prostate. Radiology. 131:1979;641-645.
33. von Eschenback A. C., Jing B., Wallace S. Lymphangiography in genitourinary cancer. Urol. Clin. N. Am. 12:1985;715-723.
34. Gothlin J. H., Hoiem L. Percutaneous fine-needle biopsy of radiographically normal lymph nodes in the staging of prostatic carcinoma. Radiology. 141:1981;351-354.
35. Spellman M. C., Castellino R. A., Ray G. R., Pistenma D. A., Bagshaw M. A. An evaluation of lymphography in localized carcinoma of the prostate. Radiology. 125:1977;637-644.
36. Wajsman Z. Lymph node evaluation in prostate cancer Is pelvic lymph node dissection necessary? Urology. 17:(Suppl.):1981;80-82.
37. Bagshaw M. A., Ray G. R., Cox R. S. Radiotherapy of prostatic carcinoma; long- or short-term efficacy (Stanford University experience). Urology. 25:(Suppl.):1985;17-23.
38. Zagars G. K., Pollack A., Kavadi V. S., von Eschenbach A. C. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;293-306.
39. Hanks G. E., Leibel S., Kramer S. The dissemination of cancer transurethral resection of locally advanced prostate cancer. J. Urol. 129:1983;309-311.
40. Kuban D. A., El-Mahdi A. M., Schelhammer P.F., Babb T. J. The effect of transurethral prostatic resection on the incidence of osseous prostatic metastasis. Cancer. 56:1985;961-964.
41. Levine E. S., Cisek V. J., Mulvihill M. N., Cohen E. L. Role of transurethral resection in dissemination of cancer of the prostate. Urology. 28:1986;179-183.
42. McGowan D. G. The adverse influence of prior transurethral resection on prognosis in carcinoma of the prostate treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 6:1980;1121-1126.
43. Sandler H. M., Hanks G. E. Analysis of the possibility that transurethral resection promotes metastasis in prostate cancer. Cancer. 62:1988;2622-2627.
44. Zagars G. K., Ayala A. G., von Eschenbach A. C., Pollack A. The prognostic importance of Gleason grade in prostatic adenocarcinoma A long-term follow-up of 648 patients treated with radiation therapy . Int. J. Radiat. Oncol. Biol. Phys. 31:1995;237-245.
45. Meecham R. B., Scardino P. T., Hoffman G. S., Easley J. D., Wilbanks J. H., Carlton C. E. Jr. The risk of metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J. Urol. 144:1989;320-325.
46. Stamey T. A., Ferrari M. K., Schmid H. P. The value of serial prostate specific antigen determinations 5 years after radiotherapy Steeply increasing values characterize 80% of patients . J. Urol. 150:1993;1856-1859.